Clinical & experimental neuroimmunology

Keyphrases

Publications

volume 15, number 1, 2023

Amna Siddiqui, Dylan Ross, Ronak H Jani, Vikram C Prabhu, Shelly Lo, Derek A Wainwright, Stasia Rouse, Tamer Refaat, Yirong Zhu, Jigisha P Thakkar
Anti-aquaporin-4 immunoglobulin G/anti-myelin oligodendrocyte glycoprotein immunoglobulin G double-positive paraneoplastic neurological syndrome in a patient with triple-negative breast cancer. Clinical & experimental neuroimmunology 15 (1) (2023)
Amna Siddiqui, Dylan Ross, Ronak H Jani, Vikram C Prabhu, Shelly Lo, Derek A Wainwright, Stasia Rouse, Tamer Refaat, Yirong Zhu, Jigisha P Thakkar
Anti-aquaporin-4 immunoglobulin G/anti-myelin oligodendrocyte glycoprotein immunoglobulin G double-positive paraneoplastic neurological syndrome in a patient with triple-negative breast cancer. Clinical & experimental neuroimmunology 15 (1) (2023)
Amna Siddiqui, Dylan Ross, Ronak H Jani, Vikram C Prabhu, Shelly Lo, Derek A Wainwright, Stasia Rouse, Tamer Refaat, Yirong Zhu, Jigisha P Thakkar
Anti-aquaporin-4 immunoglobulin G/anti-myelin oligodendrocyte glycoprotein immunoglobulin G double-positive paraneoplastic neurological syndrome in a patient with triple-negative breast cancer. Clinical & experimental neuroimmunology 15 (1) (2023)

2022

Sidhartha Chattopadhyay, Judhajit Sengupta, Sagar Basu
Post-infectious cerebellar ataxia following COVID-19 in a patient with epilepsy. Clinical & experimental neuroimmunology (2022)
Khalil Hajiasgharzadeh, Mahdi Jafarlou, Behzad Mansoori, Narges Dastmalchi, Behzad Baradaran, Alireza Khabbazi
Inflammatory reflex disruption in COVID-19. Clinical & experimental neuroimmunology (2022)
Finsterer Josef
All differential diagnoses of cerebellar ataxia should be ruled out before SARS-CoV-2 is blamed as the cause. Clinical & experimental neuroimmunology (2022)
Finsterer Josef
All differential diagnoses of cerebellar ataxia should be ruled out before SARS-CoV-2 is blamed as the cause. Clinical & experimental neuroimmunology (2022)

volume 13, number 2, 2022

Finsterer Josef, Daniel Matovu, Fulvio Alexandre Scorza
Nerve conduction studies support the classification of SARS-CoV-2 associated Guillain-Barre subtypes. Clinical & experimental neuroimmunology 13 (2) (2022)
Gustavo Figueiredo da Silva, Caroline Figueiredo da Silva, Raddib Eduardo Noleto da Nobrega Oliveira, Fabiana Romancini, Rafael Marques Mendes, Amanda Locks, Maria Francisca Moro Longo, Carla Heloisa Cabral Moro, Alexandre Luiz Longo, Vera Lucia Braatz
Response to "Nerve conduction studies support the classification of SARSCoV-2 associated Guillain-Barre subtypes". Clinical & experimental neuroimmunology 13 (2) (2022)

2021

Ryo Tanaka, Takamasa Nukui, Ratna Dini Haryuni, Makoto Mori, Shigeru Hayashi, Kyo Noguchi, Yuji Nakatsuji
Radial linear perivascular emphasis in coronavirus disease 2019-associated acute disseminated encephalomyelitis. Clinical & experimental neuroimmunology (2021)
Haruki Koike, Masahisa Katsuno
Emerging infectious diseases, vaccines and Guillain-Barré syndrome. Clinical & experimental neuroimmunology (2021)

volume 13, number 1, 2021

Takayoshi Shimohata
Neuro-COVID-19. Clinical & experimental neuroimmunology 13 (1) (2021)

volume 13, number 2, 2021

Gustavo Figueiredo da Silva, Caroline Figueiredo da Silva, Raddib Eduardo Noleto da Nobrega Oliveira, Fabiana Romancini, Rafael Marques Mendes, Amanda Locks, Maria Francisca Moro Longo, Carla Heloisa Cabral Moro, Alexandre Luiz Longo, Vera Lucia Braatz
Guillain-Barré syndrome after coronavirus disease 2019 vaccine: A temporal association. Clinical & experimental neuroimmunology 13 (2) (2021)
Christian García-Estrada, Enrique Gomez-Figueroa, Lennyn Alban, Alejandro Arias-Cárdenas
Optic neuritis after COVID-19 vaccine application. Clinical & experimental neuroimmunology 13 (2) (2021)

volume 9, number 3, 2018

Kathryn B Holroyd, Faisal Aziz, Miklos Szolics, Taoufik Alsaadi, Michael Levy, Nicoline Schiess
Prevalence and characteristics of transverse myelitis and neuromyelitis optica spectrum disorders in the United Arab Emirates: A multicenter, retrospective study. Clinical & experimental neuroimmunology 9 (3) (2018)

volume 9, number 4, 2018

Takashi Saito, Takaomi C Saido
Neuroinflammation in mouse models of Alzheimer's disease. Clinical & experimental neuroimmunology 9 (4) (2018)
Emiliano Trias, Luis Barbeito, Koji Yamanaka
Phenotypic heterogeneity of astrocytes in motor neuron disease. Clinical & experimental neuroimmunology 9 (4) (2018)

volume 8, number 2, 2017

Takashi Yamamura, Natalia Ashtamker, David Ladkani, Toshiyuki Fukazawa, Hideki Houzen, Masami Tanaka, Toshiro Miura, Volker Knappertz
Once-daily glatiramer acetate decreases magnetic resonance imaging disease activity in Japanese patients with relapsing-remitting multiple sclerosis. Clinical & experimental neuroimmunology 8 (2) (2017)

volume 8, number 3, 2017

Ah-Mee Park, Seiichi Omura, Mitsugu Fujita, Fumitaka Sato, Ikuo Tsunoda
Helicobacter pylori and gut microbiota in multiple sclerosis versus Alzheimer's disease: 10 pitfalls of microbiome studies. Clinical & experimental neuroimmunology 8 (3) (2017)
Fumihito Yoshii, Yusuke Moriya, Tomohide Ohnuki, Masafuchi Ryo, Wakoh Takahashi
Neurological safety of fingolimod: An updated review. Clinical & experimental neuroimmunology 8 (3) (2017)
Ikuo Tsunoda
Lymphatic system and gut microbiota affect immunopathology of neuroinflammatory diseases, including multiple sclerosis, neuromyelitis optica and Alzheimer's disease. Clinical & experimental neuroimmunology 8 (3) (2017)

volume 8, number 4, 2017

Mieko Ogino, Shuichi Okamoto, Hiroyuki Ohta, Mariko Sakamoto, Yusuke Nakamura, Kosuke Iwasaki, Manami Yoshida, Shinzo Hiroi, Izumi Kawachi
Prevalence, treatments and medical cost of multiple sclerosis in Japan based on analysis of a health insurance claims database. Clinical & experimental neuroimmunology 8 (4) (2017)

volume 8, number Suppl Suppl 1, 2017

Bleranda Zeka, Hans Lassmann, Monika Bradl
Müller cells and retinal axons can be primary targets in experimental neuromyelitis optica spectrum disorder. Clinical & experimental neuroimmunology 8 (Suppl Suppl 1) (2017)

volume 7, number 2, 2016

Joe C Udeochu, Jeremy M Shea, Saul A Villeda
Microglia communication: Parallels between aging and Alzheimer's disease. Clinical & experimental neuroimmunology 7 (2) (2016)
Mieko Ogino, Izumi Kawachi, Kazuyoshi Otake, Hiroyuki Ohta, Yujiro Otsuka, Kosuke Iwasaki, Shinzo Hiroi
Current treatment status and medical cost for multiple sclerosis based on analysis of a Japanese claims database. Clinical & experimental neuroimmunology 7 (2) (2016)

volume 7, number 4, 2016

Ikuo Tsunoda, Fumitaka Sato, Seiichi Omura, Mitsugu Fujita, Namie Sakiyama, Ah-Mee Park
Three immune-mediated disease models induced by Theiler's virus: Multiple sclerosis, seizures and myocarditis. Clinical & experimental neuroimmunology 7 (4) (2016)

volume 6, number 3, 2015

Kakulavarapu V Rama Rao, Tammy Kielian
Neuron-astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation. Clinical & experimental neuroimmunology 6 (3) (2015)
Elisabeth R Mari, Jason N Moore, Guang-Xian Zhang, Abdolmohamad Rostami
Mechanisms of immunological tolerance in central nervous system inflammatory demyelination. Clinical & experimental neuroimmunology 6 (3) (2015)

volume 6, number 4, 2015

Maureen A Mealy, Kyong Shin, Gareth John, Michael Levy
Bevacizumab is safe in acute relapses of neuromyelitis optica. Clinical & experimental neuroimmunology 6 (4) (2015)

volume 5, number 3, 2014

Patrick J Waters, Sean J Pittock, Jeffrey L Bennett, Sven Jarius, Brian G Weinshenker, Dean M Wingerchuk
Evaluation of aquaporin-4 antibody assays. Clinical & experimental neuroimmunology 5 (3) (2014)